Millbrook Press Inc Sample Contracts

AutoNDA by SimpleDocs
JOINT FILING AGREEMENT
Joint Filing Agreement • July 18th, 2002 • Millbrook Press Inc • Books: publishing or publishing & printing

In accordance with Rule 13d-1 under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing on behalf of each of them of a statement on Schedule 13D (including amendments thereto) with respect to the Common Stock, $0.01 par value per share, of The Millbrook Press, Inc. and that this Agreement be included as an Exhibit to such joint filing.

UNDERWRITING AGREEMENT between PROTAGENIC THERAPEUTICS, INC. and KINGSWOOD CAPITAL MARKETS, division of Benchmark Investments, Inc., as Representative of the Several Underwriters PROTAGENIC THERAPEUTICS, INC. UNDERWRITING AGREEMENT
Underwriting Agreement • April 30th, 2021 • Protagenic Therapeutics, Inc.\new • Services-business services, nec • New York

The undersigned, Protagenic Therapeutics, Inc., a corporation formed under the laws of the State of Delaware (the “Company”), hereby confirms its agreement (this “Agreement”) with Kingswood Capital Markets, division of Benchmark Investments, Inc. (hereinafter referred to as “you” (including its correlatives) or the “Representative”), and with the other underwriters named on Schedule 1 hereto for which the Representative is acting as representative (the Representative and such other underwriters being collectively called the “Underwriters” or, individually, an “Underwriter”) as follows:

RECITALS
Contribution Agreement • October 22nd, 1996 • Millbrook Press Inc • Delaware
Form of Registration Rights Agreement
Registration Rights Agreement • January 26th, 2007 • MPLC, Inc. • Books: publishing or publishing & printing • Delaware

THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is entered into as of the 24th day of January, 2007, by and among MPLC, Inc., a Delaware corporation (the “Company”), and the undersigned parties listed under Investors on the signature page hereto (each, an “Investor” and collectively, the “Investors”).

ARTICLE I DEFINITIONS
Securities Purchase Agreement • March 6th, 2007 • MPLC, Inc. • Books: publishing or publishing & printing • New York
SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • June 1st, 2011 • Atrinsic, Inc. • Services-business services, nec • Illinois

This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of May 31, 2011, is by and among Atrinsic, Inc., a Delaware corporation (the “Company”), and the investors listed on the Schedule of Buyers attached hereto (individually, a “Buyer” and collectively, the “Buyers”).

REGISTRATION RIGHTS AGREEMENT
Registration Rights Agreement • June 1st, 2011 • Atrinsic, Inc. • Services-business services, nec • New York

This REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of May 31, 2011, is by and among Atrinsic, Inc., a Delaware corporation (the “Company”), and each of the undersigned buyers (each, a “Buyer,” and collectively, the “Buyers”).

RECITALS
Indemnification Agreement • October 22nd, 1996 • Millbrook Press Inc • Delaware
RECITALS
Escrow Agreement • June 10th, 2005 • MPLC, Inc. • Books: publishing or publishing & printing • New York
1,500,000 SHARES OF COMMON STOCK AND 1,500,000 COMMON STOCK PURCHASE WARRANTS
Underwriting Agreement • December 6th, 1996 • Millbrook Press Inc • Books: publishing or publishing & printing • New York
Registration Rights Agreement
Registration Rights Agreement • April 18th, 2016 • Atrinsic, Inc. • Services-business services, nec • New York

This Registration Rights Agreement (this “Agreement”) is made and entered into effective as of _______, 2016 (the “Effective Date”) between Atrinsic, Inc., a Delaware corporation (the “Company”), and the persons who have executed the signature page(s) hereto (each, a “Purchaser” and collectively, the “Purchasers”).

AutoNDA by SimpleDocs
SERIES A COMMON STOCK PURCHASE WARRANT PROTAGENIC THERAPEUTICS, Inc.
Protagenic Therapeutics, Inc.\new • October 30th, 2024 • Pharmaceutical preparations

THIS SERIES A COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on ______________ (the “Termination Date”) but not thereafter, to subscribe for and purchase from Protagenic Therapeutics, Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of the Company’s Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

MILLBROOK PRESS 2 Old New Milford Road Brookfield, CT 06804
Millbrook Press Inc • December 13th, 1996 • Books: publishing or publishing & printing • Connecticut
SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • October 30th, 2024 • Protagenic Therapeutics, Inc.\new • Pharmaceutical preparations • New York

This Securities Purchase Agreement (this “Agreement”) is dated as of October 29, 2024, between Protagenic Therapeutics, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).

The Millbrook Press Incorporated 2 Old New Milford Road Brookfield, Connecticut 06804
Employment Agreement • December 13th, 1996 • Millbrook Press Inc • Books: publishing or publishing & printing
PROTAGENIC THERAPEUTICS, INC. Common Stock (par value $0.0001 per share) At Market Issuance Sales Agreement
Common Stock • July 2nd, 2021 • Protagenic Therapeutics, Inc.\new • Services-business services, nec • New York
INCENTIVE STOCK OPTION GRANT AGREEMENT PROTAGENIC THERAPEUTICS, INC.
Incentive Stock Option Grant Agreement • June 20th, 2016 • Atrinsic, Inc. • Services-business services, nec • Delaware

This Stock Option Grant Agreement (the “Grant Agreement”) is made and entered into effective on the Date of Grant set forth in Exhibit A (the “Date of Grant”) by and between Protagenic Therapeutics, Inc., a Delaware corporation (the “Company”), and the individual named in Exhibit A hereto (the “Optionee”).

NONQUALIFIED STOCK OPTION GRANT AGREEMENT PROTAGENIC THERAPEUTICS, INC.
Nonqualified Stock Option Grant Agreement • June 20th, 2016 • Atrinsic, Inc. • Services-business services, nec • Delaware

This Stock Option Grant Agreement (the “Grant Agreement”) is made and entered into effective on the Date of Grant set forth in Exhibit A (the “Date of Grant”) by and between Protagenic Therapeutics, Inc., a Delaware corporation (the “Company”), and the individual named in Exhibit A hereto (the “Optionee”).

SECURITY AGREEMENT
Security Agreement • June 1st, 2011 • Atrinsic, Inc. • Services-business services, nec • New York

This SECURITY AGREEMENT (this “Agreement”), dated as of May 31, 2011, is made by and among the grantors listed on the signature pages hereof (collectively, jointly and severally, the “Grantors” and each, individually, a “Grantor”), and the secured parties listed on the signature pages hereof (collectively, the “Secured Parties” and each, individually, a “Secured Party”).

KATALYST SECURITIES LLC NEW YORK, NY 10038 TEL: 212-587-6667 Member: FINRA & SIPC PLACEMENT AGENCY AGREEMENT
Placement Agency Agreement • April 18th, 2016 • Atrinsic, Inc. • Services-business services, nec • New York

This Placement Agency Agreement (“Agreement”) sets forth the terms upon which Katalyst Securities LLC (“Katalyst”), registered broker-dealer and member of the Financial Industry Regulatory Authority (“FINRA”) (hereinafter referred to as the “Placement Agent”), shall be engaged by Atrinsic, Inc., a publicly traded Delaware Corporation (hereinafter referred to as the “Company”), to act as exclusive Placement Agent in connection with the private placement (the “Offering”) of the securities of the Company (the “Securities”). The initial closing of the Offering will be conditioned upon and acceptance of subscriptions for the Minimum Amount (as defined below) and the consummation of a reverse triangular merger (the “Merger”) by and among a subsidiary of the Company, Protagenic Therapeutics Inc. (“PTI”), a privately held Delaware corporation, and the Company and certain other transactions described herein, pursuant to which PTI will become a wholly owned subsidiary of the Company, and all of

STANDARDIZED ADOPTION AGREEMENT
Standardized Adoption Agreement • October 22nd, 1996 • Millbrook Press Inc
Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!